Lifecore Biomedical swung to a loss despite posting higher revenue in its fiscal second quarter, boosted by new project agreements. The Chaska, Minn., company, which develops and manufactures pharmaceutical products, on Thursday reported a loss of $6.6 million for the quarter ended Nov. 24, compared with a profit of $14.2 million a year earlier.

Lifecore Biomedical, Inc. ( (LFCR) ) has released its Q2 earnings. Here is a breakdown of the information Lifecore Biomedical, Inc. presented

CHASKA, Minn. — CHASKA, Minn. — Lifecore Biomedical, Inc. (LFCR) on Thursday reported a loss of $8.7 million in its fiscal second quarter. On a per-share basis, the Chaska, Minnesota-based company said it had a loss of 25 cents. The agricultural and food packaging products company posted revenue of $32.6 million in the period.

Lifecore Biomedical (LFCR) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.06 per share a year ago. These figures are adjusted for non-recurring items.